FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1964302034> ?p ?o ?g. }

• W1964302034 endingPage "329" @default.
• W1964302034 startingPage "323" @default.
• W1964302034 abstract "The authors hypothesized that adherence to anti-inflammatory treatment could reduce overall cost of asthma care, as higher spending on drugs would be offset by reductions in hospital and emergency care.A retrospective observational study using 2 years of claims data for 41,234 commercially insured asthmatics on monotherapy with either leukotriene inhibitors (LI) or inhaled corticosteriods (ICS). Patients were grouped into adherence quartiles based on the percentage of days per year they had prescriptions filled (medication possession ratio). The relationship between adherence and four outcomes was examined: ( 1 ) emergency department (ED) visits, ( 2 ) hospitalizations, ( 3 ) nondrug net payments for asthma care, ( 4 ) total net payments for asthma care (including drug costs). Multivariate and logistic regression models adjusting for demographics, comorbidities, and measures of past asthma utilization were used.Adherence rates were low with a median medication possession ratio of 39% for LI and 15% for ICS. Both ED and hospital use was negatively associated with adherence to LI. Patients in the lowest quartile experienced 80 (95% confidence interval (CI) = 62-102) ED visits and 34 (95% CI = 22-52) admissions per 1000 patient-years compared to 36 (95% CI = 27-49) ED visits and 13 (95% CI = 8-22) admissions in the highest quartile. In contrast, ED visits and hospital admissions did not differ significantly between adherence groups for ICS. Total payments for asthma care increased significantly with higher adherence for both LI and ICS patients. Comparing the lowest and highest adherence quartile, payments per person per month increased significantly from $65.11 (95% CI = $57.02-$73.20) to $147.46 (95% CI = $139.48-$155.44) for patients on LI and from $38.71 (95% CI = $29.52-$47.90) to 93.13 (95% CI = $83.70-$102.56) for patients on ICS. The only subgroup, for which overall asthma payments did not increase with better adherence, were patients with past ED visit or hospital admission on LI.In this observational study, treatment with LI, but not with ICS, appears to improve disease control, as evidenced by the reduction in the incidence of ED visits and hospitalizations in patients on LI. Savings generated by this reduction in high-cost events don't offset the increased payments for drugs in more adherence patients, except for selected high-risk patients." @default.
• W1964302034 created "2016-06-24" @default.
• W1964302034 creator A5013836346 @default.
• W1964302034 creator A5022581727 @default.
• W1964302034 creator A5030183504 @default.
• W1964302034 creator A5040077796 @default.
• W1964302034 creator A5051195547 @default.
• W1964302034 creator A5089262178 @default.
• W1964302034 date "2010-04-01" @default.
• W1964302034 modified "2023-09-23" @default.
• W1964302034 title "Anti-inflammatory Medication Adherence and Cost and Utilization of Asthma Care in a Commercially Insured Population" @default.
• W1964302034 cites W1971099282 @default.
• W1964302034 cites W1985563285 @default.
• W1964302034 cites W1991175181 @default.
• W1964302034 cites W1991968623 @default.
• W1964302034 cites W2006499560 @default.
• W1964302034 cites W2009200551 @default.
• W1964302034 cites W2025939066 @default.
• W1964302034 cites W2031473835 @default.
• W1964302034 cites W2035876673 @default.
• W1964302034 cites W2040064628 @default.
• W1964302034 cites W2042283673 @default.
• W1964302034 cites W2055482070 @default.
• W1964302034 cites W2061391567 @default.
• W1964302034 cites W2092241765 @default.
• W1964302034 cites W2133921313 @default.
• W1964302034 cites W2139122730 @default.
• W1964302034 cites W2149554221 @default.
• W1964302034 cites W2154662363 @default.
• W1964302034 cites W2157029647 @default.
• W1964302034 cites W2168777185 @default.
• W1964302034 doi "https://doi.org/10.3109/02770900903497196" @default.
• W1964302034 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20394518" @default.
• W1964302034 hasPublicationYear "2010" @default.
• W1964302034 type Work @default.
• W1964302034 sameAs 1964302034 @default.
• W1964302034 citedByCount "36" @default.
• W1964302034 countsByYear W19643020342012 @default.
• W1964302034 countsByYear W19643020342013 @default.
• W1964302034 countsByYear W19643020342014 @default.
• W1964302034 countsByYear W19643020342015 @default.
• W1964302034 countsByYear W19643020342016 @default.
• W1964302034 countsByYear W19643020342017 @default.
• W1964302034 countsByYear W19643020342018 @default.
• W1964302034 countsByYear W19643020342019 @default.
• W1964302034 countsByYear W19643020342020 @default.
• W1964302034 countsByYear W19643020342021 @default.
• W1964302034 countsByYear W19643020342022 @default.
• W1964302034 crossrefType "journal-article" @default.
• W1964302034 hasAuthorship W1964302034A5013836346 @default.
• W1964302034 hasAuthorship W1964302034A5022581727 @default.
• W1964302034 hasAuthorship W1964302034A5030183504 @default.
• W1964302034 hasAuthorship W1964302034A5040077796 @default.
• W1964302034 hasAuthorship W1964302034A5051195547 @default.
• W1964302034 hasAuthorship W1964302034A5089262178 @default.
• W1964302034 hasConcept C118552586 @default.
• W1964302034 hasConcept C126322002 @default.
• W1964302034 hasConcept C151956035 @default.
• W1964302034 hasConcept C156957248 @default.
• W1964302034 hasConcept C167135981 @default.
• W1964302034 hasConcept C194828623 @default.
• W1964302034 hasConcept C2426938 @default.
• W1964302034 hasConcept C2776042228 @default.
• W1964302034 hasConcept C2780724011 @default.
• W1964302034 hasConcept C2908647359 @default.
• W1964302034 hasConcept C44249647 @default.
• W1964302034 hasConcept C68443243 @default.
• W1964302034 hasConcept C71924100 @default.
• W1964302034 hasConcept C98274493 @default.
• W1964302034 hasConcept C99454951 @default.
• W1964302034 hasConceptScore W1964302034C118552586 @default.
• W1964302034 hasConceptScore W1964302034C126322002 @default.
• W1964302034 hasConceptScore W1964302034C151956035 @default.
• W1964302034 hasConceptScore W1964302034C156957248 @default.
• W1964302034 hasConceptScore W1964302034C167135981 @default.
• W1964302034 hasConceptScore W1964302034C194828623 @default.
• W1964302034 hasConceptScore W1964302034C2426938 @default.
• W1964302034 hasConceptScore W1964302034C2776042228 @default.
• W1964302034 hasConceptScore W1964302034C2780724011 @default.
• W1964302034 hasConceptScore W1964302034C2908647359 @default.
• W1964302034 hasConceptScore W1964302034C44249647 @default.
• W1964302034 hasConceptScore W1964302034C68443243 @default.
• W1964302034 hasConceptScore W1964302034C71924100 @default.
• W1964302034 hasConceptScore W1964302034C98274493 @default.
• W1964302034 hasConceptScore W1964302034C99454951 @default.
• W1964302034 hasIssue "3" @default.
• W1964302034 hasLocation W19643020341 @default.
• W1964302034 hasLocation W19643020342 @default.
• W1964302034 hasOpenAccess W1964302034 @default.
• W1964302034 hasPrimaryLocation W19643020341 @default.
• W1964302034 hasRelatedWork W1994701619 @default.
• W1964302034 hasRelatedWork W2037611947 @default.
• W1964302034 hasRelatedWork W2055211800 @default.
• W1964302034 hasRelatedWork W2095857282 @default.
• W1964302034 hasRelatedWork W2116633522 @default.
• W1964302034 hasRelatedWork W2335988042 @default.
• W1964302034 hasRelatedWork W2899869010 @default.
• W1964302034 hasRelatedWork W4307230793 @default.

• next